SCHEMBL10135113

SCHEMBL10135113

N#Cc1ccc2c(c1)nc(Oc1ccc3ncccc3c1)c1ccsc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 3/20 0.38
SCN9A Q15858 4/20 0.36
PDE10A Q9Y233 4/20 0.36
CSNK1A1 P48729 2/20 0.36
CSNK1D P48730 1/20 0.36
GSK3B P49841 1/20 0.36
CSNK1G2 P78368 1/20 0.36
KDR P35968 1/20 0.36
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
DAPK3 O43293 1/20 0.33
MAP4K4 O95819 1/20 0.33
PRKACA P17612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11932272 0.84 MAPT (0.47) CSNK2A1KDRMAPTHTTCSNK2A2
SCHEMBL2689569 0.82 CSNK2A1 (0.44) CSNK2A1CSNK1A1CSNK1DMAPTHTT
SCHEMBL10135110 0.81 CSNK2A1 (0.39) CSNK2A1CSNK2A2CSNK2BMAP4K4
SCHEMBL10135115 0.81 CSNK2A1 (0.42) CSNK2A1SCN9AMAPTCSNK2A2CSNK2B
SCHEMBL10135116 0.80 CYP19A1 (0.43) CSNK2A1MAPTCSNK2A2CSNK2BALDH1A1
SCHEMBL10135114 0.76 RAB9A (0.47) CSNK2A1MAPTCSNK2A2CSNK2BALDH1A1
SCHEMBL10135098 0.73 CSNK2A1 (0.45) CSNK2A1CSNK2A2CSNK2BCDK8
SCHEMBL10135095 0.72 CSNK2A1 (0.43) CSNK2A1CSNK1A1GSK3BCSNK2A2CSNK2B
SCHEMBL10135099 0.70 CSNK2A1 (0.47) CSNK2A1CSNK2A2CSNK2B
SCHEMBL31588535 0.70 POLB (0.57) MAPTHTTALDH1A1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120208792-A1 PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2012-08-16 US disclosed
US-20120208792-A1 PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2012-08-16 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208792-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 CSNK2A1 680/4885SCN9A 4763/4885PDE10A 1921/4885
US-20090239859-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 CSNK2A1 680/4885SCN9A 4763/4885PDE10A 1921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.